A análise estratégica como orientação ao processo de inteligência competitiva (IC) num caso empresarial do segmento industrial alimentício do vale do Taquari (VT/RS)

Esta pesquisa, desenvolvida sob forma de estudo de caso, teve como objetivo verificar a aplicabilidade de modelos e de métodos de análise estratégica para compreender e orientar o processo de inteligência competitiva numa empresa. A empresa selecionada pertence ao segmento alimentício do setor de candies. A pesquisa envolveu cinco etapas: a) levantamento de métodos de análise e contato com o setor; b) conhecimento da empresa; c) conhecimento do ambiente concorrencial; d) aplicação dos modelos de análise e coleta de informações; e) validação interna dos procedimentos metodológicos. Como resultado foram identificadas, as principais variáveis do ambiente concorrencial, as variáveis sobre as quais a empresa deverá aprimorar seu processo de monitoramento e a necessidade de distribuir internamente as informações capturadas. A validação interna, realizada com o grupo diretivo da empresa, permite considerar que a metodologia é pertinente ao objeto estudado e aporta informações e conhecimentos consideráveis às fases preliminares da implantação do processo de inteligência competitiva em pequenas e médias empresas (PMEs).

The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL)

Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patients with APL treated with the combination of all trans retinoic acid (ATRA) and anthracyclines. Nevertheless, the results observed in developing countries with the same regimen was poorer, mainly due to high early mortality mainly due bleeding. The International Consortium on Acute Promyelocytic Leukemia (IC-APL) is an initiative of the International Members Committee of the ASH and the project aims to reduce this gap through the establishment of international network, which was launched in Brazil, Mexico and Uruguay. Methods: The IC-APL treatment protocol is similar to the PETHEMA 2005, but changing idarubicin to daunorubicin. All patients with a suspected diagnosis of APL were immediately started on ATRA, while bone marrow samples were shipped to a national central lab where genetic verification of the diagnosis was performed. The immunofluorescence using an anti-PML antibody allowed a rapid confirmation of the diagnosis and, the importance of supportive measures was reinforced. Results: The interim analysis of 97 patients enrolled in the IC-APL protocol showed that complete remission (CR) rate was 83% and the 2-year overall survival and disease-free survival were 80% and 90%, respectively. Of note, the early mortality rate was reduced to 7.5%. Discussion: The results of IC-APL demonstrate the impact of educational programs and networking on the improvement of the leukemia treatment outcome in developing countries.

Super shell logic - [sush-ic] - progetto di un edificio per il tempo libero a Tokyo. Implicazioni tettoniche ed estetiche delle logiche monoscocca integrate e stress lines analysis in architettura.

Implicazioni tettoniche ed estetiche delle logiche monoscocca integrate e stress lines analysis in architettura.

A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic

Carbohydrate-deficient glycoprotein syndrome (CDGS) represents a class of genetic diseases characterized by abnormal N-linked glycosylation. CDGS patients show a large number of glycoprotein abnormalities resulting in dysmorphy, encephalopathy, and other organ disorders. The majority of CDGSs described to date are related to an impaired biosynthesis of dolichyl pyrophosphate-linked Glc3Man9GlcNAc2 in the endoplasmic reticulum. Recently, we identified in four related patients a novel type of CDGS characterized by an accumulation of dolichyl pyrophosphate-linked Man9GlcNAc2. Elaborating on the analogy of this finding with the phenotype of alg5 and alg6 Saccharomyces cerevisiae strains, we have cloned and analyzed the human orthologs to the ALG5 dolichyl phosphate glucosyltransferase and ALG6 dolichyl pyrophosphate Man9GlcNAc2 alpha1,3-glucosyltransferase in four novel CDGS patients. Although ALG5 was not altered in the patients, a C-->T transition was detected in ALG6 cDNA of all four CDGS patients. The mutation cosegregated with the disease in a Mendelian recessive manner. Expression of the human ALG5 and ALG6 cDNA could partially complement the respective S. cerevisiae alg5 and alg6 deficiency. By contrast, the mutant ALG6 cDNA of CDGS patients failed to revert the hypoglycosylation observed in alg6 yeasts, thereby proving a functional relationship between the alanine to valine substitution introduced by the C-->T transition and the CDGS phenotype. The mutation in the ALG6 alpha1,3-glucosyltransferase gene defines an additional type of CDGS, which we propose to refer to as CDGS type-Ic.

Fragm. germ. III 5 - Sachsenspiegel, 3. deutsche Fassung, Ordnung Ic

Trägerband: Inc. qu. 681; Vorbesitzer: Karmeliterkloster Frankfurt am Main